Sp568
PANEL DISCUSSION
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
CURRENT AND EMERGING THERAPIES FOR ALCOHOL ASSOCIATED LIVER DISEASE
Alcohol associated liver disease is still a very common entity. The session will provide a comprehensive approach to the aforementioned disease including clinical presentations, diagnosis and emerging treatments including liver transplant…
BENEFICIAL EFFECTS OF N-3 PUFA SUPPLEMENTATION ON LIVER INJURY, ENDOTOXEMIA, AND INFLAMMATION IN HEAVY DRINKING INDIVIDUALS
BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…